New Therapies for Kidney Disease with XORTX Therapeutics CEO, Allen Davidoff, PhD
Allen Davidoff, PhD is the Founder and CEO of XORTX Therapeutics, Inc., a drug based biotechnology company primarily focused on orphan disease indications which have aberrant purine metabolism and frequently high serum uric acid imbalance. This podcast episodes looks at novel therapies in development that may extend kidney health.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.